Bain utilise des cookies pour améliorer la fonctionnalité et la performance de ce site. En poursuivant votre navigation suce site, vous acceptez l’utilisation des cookies. Pour plus d’informations, veuillez-vous référer à notre politique de confidentialité

We have French content available. View French site.

Étude de cas

Pharma oncology growth strategy

A leading player in the oncology market was seeking to grow in the face of increasing competition, regulation and other pressures. Bain created a framework to help the pharmaceutical company optimize its portfolio to support the company's revenue goals, and developed a plan for the company to close the revenue gap by making the most of its existing investments.

  • min

Toute l’histoire

The Situation

  • Pharma Co.* is a leading player in the oncology market and wants to grow and retain its competitive position
  • Oncology market is growing, but is increasingly competitive and increasingly impacted by payers/regulators
  • Pharma Co.'s current portfolio does not support revenue goals within oncology
  • Project prioritization is complex due to uncertainty of compounds having multiple indications
  • Existing process and tools are not effective for making strategic trade-offs for single compounds and entire portfolio

Our Approach

Improve the NPD process:

The Recommendations

Develop a framework to optimize portfolio decisions:

The Results

Plan developed to close the revenue gap:

 

* We take our clients' confidentiality seriously. While we've changed their names, the results are real. 

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.